Convene an advisory meeting focused on facilitating public-private partnerships aimed at accelerating the development of effective therapies for AD and ADRD treatment and prevention.
Established working groups on: (i) Rapid Data Sharing and Analysis, (ii) Enabling Bidirectional Translation in AD drug development, (iii) Eliminating IP barriers for Target Validation through clinical proof of concept.
2013 to 2013
Research Implementation Area
Public Private Partnerships
G. Consortia and Public Private Partnerships